Mark J. Lewis
Ph.D., economics, Massachusetts Institute of Technology; M.A., economics, Queen’s University; B.Sc., mathematics and economics, Dalhousie University
Summary of Experience
Dr. Lewis provides economic analysis and expert witness support in a wide range of litigation matters, including antitrust, class certification, and health care cases. His case work has involved cartel allegations in a variety of industries, alleged horizontal and vertical restraints by manufacturers in the technology and construction industries, antitrust claims against brand and generic drug manufacturers, and transfer pricing disputes. Prior to joining Analysis Group, Dr. Lewis was a manager in the economic and statistical consulting group of a financial advisory firm.
- Apple Inc. v. Qualcomm Inc. (antitrust)
- Federal Trade Commission v. Qualcomm Inc.
- High-Tech Employee Class Action Involving Alleged No-Poaching Agreements
- TravelPass Group LLC et al. v. Caesars Entertainment Corp. et al.
- US v. Penn, et al.
- US, et al. v. UnitedHealth Group Inc., et al.
- Wellbutrin XL Antitrust Litigation
Economics – Overview (Measurement-Error Bias in Overcharge Calculations)
Global Competition Review: Europe, Middle East and Africa Antitrust Review 2021, July 2020
Donning And Doffing Damages: Tyson Takeaways For Antitrust
Law360, May 12, 2016
The Myth Of 'Price Disconnects' In US Pharma Markets
Law360, May 17, 2016
Stock Prices Aren't Enough For 'Rule Of Reason' Analysis
Law360, July 19, 2016
Pay-For-Delay and Stock Prices - Smoking Gun Or Damp Squib
Law360, August 24, 2016
Average overcharge models and determining individual harm in collective actions
Concurrences N° 2-2015, pp. 38-44
January 31, 2023
January 30, 2023
August 12, 2022
August 12, 2021
August 25, 2020
July 30, 2020